ISBRA 2006 World Congress on Alcohol Research

Session Details

Preclinical neuro-pharmacological studies of potential therapeutics for alcoholism

Wednesday, 13 September 2006 15:30 -17:00

Ballroom 3

Chair Michael S Cowen Howard Florey Institute University of Melbourne Parkville Vic 3010Australia
Co-Chair David H Overstreet University of North Carolina at Chapel HillUnited States

Glutamate and GABA: avenues for therapeutics?
  • Andrew J Lawrence, Howard Florey Institute, Australia
  • Metabotropic glutamate receptors – new targets for relapse prevention
  • Rainer Spanagel, Dept. of Pharmacology, Central Institute of Mental Health (ZI), University of Heidelberg, Germany
  • Assessment of alcohol craving and anti-craving drugs using the beer model in rats
  • Iain S McGregor, UNIVERSITY OF SYDNEY, Australia
  • Modification of Alcohol Intake in Alcohol-Preferring Rats by Herbal Extracts
  • David H Overstreet, University of North Carolina, Chapel Hill, NC USA, United States
  • Published on Thursday, 7 September 2006 by the Professional Conference Organiser